Literature DB >> 6480121

Causes of death in Minamata disease: analysis of death certificates.

H Tamashiro, H Akagi, M Arakaki, M Futatsuka, L H Roht.   

Abstract

The causes of death in Minamata disease were analyzed and compared with those of control subjects. Of the 1422 Minamata disease patients in the Kumamoto Prefecture, 378 had died by the end of 1980. Of these 378, the first death occurred in 1954 with a peak incidence in 1956 when Minamata disease was officially reported for the first time. The number of deaths increased rapidly after 1972 with a second peak in 1976. The male:female ratio was 1.8:1 and the mean age-at-death was 67.2 years (SD = +/- 18.65). The mean age-at-death was younger in the cases of the initial outbreak than in those recently. There were, on the average, 2.8 causes of death per person. Of these cases, 157 (41.5%) had Minamata disease indicated on the death certificate, though 64 (16.9%) had Minamata disease coded as the underlying cause. Minamata disease and the noninflammatory diseases of the central nervous system (CNS) were the main underlying causes of death between 1954 and 1969, while, in the multiple cause data, pneumonia and non-ischemic heart disease were the most prevalent. Cerebrovascular diseases (18.0%) were the main underlying causes of death followed by malignant neoplasms (14.7%), cardiovascular diseases (14.1%) and Minamata disease (14.1%) in 1970 or later, while cardiovascular diseases (18.6%), Minamata disease (14.5%), cerebrovascular diseases (10.4%) and malignant neoplasms (7.1%) were the major multiple causes of death. As compared with the control, the proportions of deaths due to noninflammatory diseases of CNS and pneumonia were higher in the initial outbreak. Although the difference in the causes of death was less apparent recently, malignant neoplasms and hypertensive diseases tended to be lower. These results suggest that there is a need for a long-term follow-up of Minamata disease patients. The data also show the potential value of multiple causes of death coding in analyses of mortality.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6480121     DOI: 10.1007/bf00378516

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  4 in total

1.  Studies on the origin of the causative agent of Minamata disease. III. Industrial wastes containing mercury compounds from Minamata Factory.

Authors:  K IRUKAYAMA; F KAI; M FUJIKI; T KONDO
Journal:  Kumamoto Med J       Date:  1962-06-30

2.  Minamata disease. The outbreak of a neurologic disorder in Minamata, Japan, and its relationship to the ingestion of seafood contaminated by mercuric compounds.

Authors:  L T KURLAND; S N FARO; H SIEDLER
Journal:  World Neurol       Date:  1960-11

3.  Focal cerebellar and cerebellar atrophy in a human subject due to organic mercury compounds.

Authors:  D HUNTER; D S RUSSELL
Journal:  J Neurol Neurosurg Psychiatry       Date:  1954-11       Impact factor: 10.154

4.  Minamata disease with a long-term follow-up.

Authors:  T Okajima; I Mishima; H Tokuomi
Journal:  Int J Neurol       Date:  1976
  4 in total
  10 in total

1.  Mercury-methylating genes dsrB and hgcA in soils/sediments of the Three Gorges Reservoir.

Authors:  Hongxia Du; Ming Ma; Tao Sun; Xianzhu Dai; Caiyun Yang; Feng Luo; Dingyong Wang; Yasuo Igarashi
Journal:  Environ Sci Pollut Res Int       Date:  2016-12-20       Impact factor: 4.223

2.  Sex differential of methylmercury toxicity in spontaneously hypertensive rats (SHR).

Authors:  H Tamashiro; M Arakaki; H Akagi; K Hirayama; K Murao; M H Smolensky
Journal:  Bull Environ Contam Toxicol       Date:  1986-12       Impact factor: 2.151

3.  Methylmercury exposure and mortality in southern Japan: a close look at causes of death.

Authors:  H Tamashiro; M Arakaki; M Futatsuka; E S Lee
Journal:  J Epidemiol Community Health       Date:  1986-06       Impact factor: 3.710

4.  Methylmercury toxicity in spontaneously hypertensive rats (SHR).

Authors:  H Tamashiro; M Arakaki; H Akagi; K Hirayama; M H Smolensky
Journal:  Bull Environ Contam Toxicol       Date:  1986-05       Impact factor: 2.151

5.  Age standardized cancer mortality ratios in areas heavily exposed to methyl mercury.

Authors:  Takashi Yorifuji; Toshihide Tsuda; Norito Kawakami
Journal:  Int Arch Occup Environ Health       Date:  2007-03-15       Impact factor: 3.015

6.  A Prospective Study of Toenail Trace Element Levels and Risk of Skin Cancer.

Authors:  Natalie H Matthews; Michelle Koh; Wen-Qing Li; Tricia Li; Walter C Willett; Meir J Stampfer; David C Christiani; J Steven Morris; Abrar A Qureshi; Eunyoung Cho
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-19       Impact factor: 4.254

7.  Does methylmercury-induced hypercholesterolemia play a causal role in its neurotoxicity and cardiovascular disease?

Authors:  Eduardo Luiz Moreira; Jade de Oliveira; Márcio Ferreira Dutra; Danúbia Bonfanti Santos; Carlos Alberto Gonçalves; Eliane Maria Goldfeder; Andreza Fabro de Bem; Rui Daniel Prediger; Michael Aschner; Marcelo Farina
Journal:  Toxicol Sci       Date:  2012-08-17       Impact factor: 4.849

8.  Does prenatal methylmercury exposure from fish consumption affect blood pressure in childhood?

Authors:  Sally W Thurston; Pascal Bovet; Gary J Myers; Philip W Davidson; Lesley A Georger; Conrad Shamlaye; Thomas W Clarkson
Journal:  Neurotoxicology       Date:  2007-06-16       Impact factor: 4.294

9.  Oral methylmercury intoxication aggravates cardiovascular risk factors and accelerates atherosclerosis lesion development in ApoE knockout and C57BL/6 mice.

Authors:  Janayne L Silva; Paola C L Leocádio; Jonas M Reis; Gianne P Campos; Luciano S A Capettini; Giselle Foureaux; Anderson J Ferreira; Cláudia C Windmöller; Flávia A Santos; Reinaldo B Oriá; Maria E Crespo-López; Jacqueline I Alvarez-Leite
Journal:  Toxicol Res       Date:  2020-11-05

10.  Use of genetic toxicology data in U.S. EPA risk assessment: the mercury study report as an example.

Authors:  R Schoeny
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.